GlassScriptPhysician profile
Ali Tareen
NPI 1396109476
$9,588.61
in general payments reported to CMS, 2019-2025
22 companies · $914 in 2025
The $914 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $829 · 2021: $2,368 · 2022: $2,598 · 2023: $888 · 2024: $1,992 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,794.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,251.06 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Biohaven Pharmaceutical Holding Company LTD. | $1,726.23 | 2022 | |
| Spinal Simplicity, LLC | $1,535.64 | 2021-2022 | |
| Abbott Laboratories | $1,398.57 | 2022-2025 | Eterna, Proclaim, Octrode |
| Medtronic USA, INC. | $481.77 | 2020 | |
| Boston Scientific Corporation | $447.39 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $377.32 | 2021-2025 | Belbuca, Xtampza |
| Abbvie INC. | $263.36 | 2022-2025 | Ubrelvy, Qulipta |
| Nevro Corp. | $261.38 | 2021-2024 | Senza |
| Scilex Pharmaceuticals INC. | $245.70 | 2022-2025 | Ztlido |
| Azurity Pharmaceuticals, INC. | $168.35 | 2023-2025 | Horizant, Horizant |
| Amgen INC. | $88.61 | 2022 | |
| Heron Therapeutics, INC. | $80.52 | 2022 | |
| Globus Medical, INC. | $54.57 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $43.63 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $35.51 | 2025 | |
| Spr Therapeutics, INC | $31.11 | 2024-2025 | Sprint Pns System |
| Almatica Pharma LLC | $23.65 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.18 | 2022 | |
| Integra Lifesciences Corporation | $20.54 | 2021 | |
| Avanos Medical | $19.68 | 2025 | Generator |
| Lilly USA, LLC | $12.84 | 2023 | Emgality |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Tareen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.